3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
8
Observational
2
Sponsor
Cancer Type
Lymphoid
2
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Conditions
Breast Neoplasms
60
Neoplasms
58
Lung Neoplasms
32
Prostatic Neoplasms
24
Colorectal Neoplasms
24
Carcinoma, Non-Small-Cell Lung
21
Neoplastic Cells, Circulating
20
Head and Neck Neoplasms
19
Pancreatic Neoplasms
17
Melanoma
14
Ovarian Neoplasms
13
Carcinoma, Hepatocellular
12
Esophageal Neoplasms
10
Colonic Neoplasms
10
Uterine Cervical Neoplasms
9
Liver Neoplasms
9
Glioma
9
Squamous Cell Carcinoma of Head and Neck
8
Multiple Myeloma
8
Leukemia, Myeloid, Acute
8
Sarcoma
7
Neoplasm Metastasis
7
Endometrial Neoplasms
7
Stomach Neoplasms
6
Neoplasm, Residual
6
Myeloproliferative Disorders
6
Leukemia
6
Kidney Neoplasms
6
Gastrointestinal Neoplasms
6
Carcinoma, Renal Cell
6
Interventions
Rituximab
6
Polymerase Chain Reaction
6
Amplified Fragment Length Polymorphism Analysis
6
Gene Expression Profiling
5
obinutuzumab
4
Surveys and Questionnaires
4
Psychiatric Rehabilitation
4
Microarray Analysis
4
Immunohistochemistry
4
Flow Cytometry
4
Therapeutics
3
Immunoenzyme Techniques
3
Drug Therapy
3
tisagenlecleucel
2
duvelisib
2
Prednisone
2
Lenalidomide
2
Influenza Vaccines
2
Immunologic Techniques
2
Echocardiography
2
Blood Specimen Collection
2
zanubrutinib
1
tazemetostat
1
relmacabtagene autoleucel
1
pomalidomide
1
ibritumomab tiuxetan
1
deucravacitinib
1
Watchful Waiting
1
Waiting Lists
1
Vincristine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Lymphoma, Follicular
×
Blood Specimen Collection
×
Clear all
NCT05735704
2025-03-26
SANGUINE
JaxBio Ltd
Unknown
3,000 enrolled
NCT04063397
2024-01-10
ECHO
Ohio State University
Completed
27 enrolled